By Dr Lauren Brown

Preprints

Lonsdale A; Halman A; Brown L; Kosasih H; Ekert P; Oshlack A, 2022, Toblerone: detecting exon deletion events in cancer using RNA-seq, http://dx.doi.org/10.1101/2022.10.27.514132

Schmidt B; Brown LM; Ryland GL; Lonsdale A; Kosasih HJ; Ludlow LE; Majewski IJ; Blombery P; Ekert PG; Davidson NM; Oshlack A, ALLSorts: a RNA-Seq classifier for B-Cell Acute Lymphoblastic Leukemia, http://dx.doi.org/10.1101/2021.08.01.454393

Brown LM; Mayoh C; Camper KA; Tax G; Mateos PA; Li W; El-Kamand S; Sullivan P; Bradley J; Thompson PI; Chen J; Sadras T; Salomon R; Wong M; Cowley MJ; de Weck A; Lau LMS; Manoharan N; Ekert PG, CBL mutations in pediatric solid and CNS tumors are a marker of receptor tyrosine kinase activation and a potential therapeutic target, http://dx.doi.org/10.64898/2025.12.02.691063

Maksimovic J; Streeton-Cook V; Grima CV; Hanna D; Tawfic N; Ludlow LE; Brown LM; Ekert PG; Alaei S; Yoannidis D; Kosasih HJ; White DL; Ahn A; Goel S; Khaw SL; Oshlack A; Sadras T, Closing the fusion-detection gap in single-cell RNA-seq with a scalable, probe-based workflow, http://dx.doi.org/10.64898/2026.08.26.747171

Fordham AM; Brown LM; Mayoh C; Salib A; Barger ZA; Wong M; Sian TCCLK; Xie J; Gunther K; Trebilcock P; Terry RL; Barahona P; Ajuyah P; Sherstyuk A; Avila A; Cadiz R; Perkins CM; Gifford AJ; Mao J; Zhao A; O’Regan LP; Gorgels D; Lau LM; Ziegler DS; Haber M; Tyrrell V; Lock RB; Cowley MJ; Nicholls W; Daly RJ; Ekert PG; Fleuren ED, Comprehensive multi-platform tyrosine kinase profiling reveals novel actionable FGFR aberrations across pediatric and AYA sarcomas, http://dx.doi.org/10.1101/2023.07.19.548825

Hu W; Kumar A; Qi S; Sadras T; Casan J; Ma D; Brown L; Haber M; Voskoboinik I; Trapani J; Ekert P; Fareh M, Single-base precision design of CRISPR-Cas13b enables systematic silencing of oncogenic fusions, http://dx.doi.org/10.21203/rs.3.rs-1714034/v1

Hu W; Kumar A; Qi S; Sadras T; Casan JM; Ma D; Brown LM; Haber M; Voskoboinik I; Trapani JA; Ekert PG; Fareh M, Single-base precision design of CRISPR-Cas13b enables systematic silencing of oncogenic fusions, http://dx.doi.org/10.1101/2022.06.22.497105

Gu A; Schmidt B; Lonsdale A; Brown LM; Sadras T; Ekert PG; Oshlack A, TALLSorts: a T-cell acute lymphoblastic leukaemia subtype classifier using RNA-seq expression data, http://dx.doi.org/10.1101/2023.04.05.535648

Back to profile page